Ticker Scorecard - ESPR Basics Company: Esperion Therapeutics, Inc. IPO Date: June 26, 2013 Sector: Healthcare Industry: Biotech Market Cap: $344.82M Activated in VL: True Average Daily Range Avg Daily Range: $0.78 | 3.21% Avg Daily Range (30 D): $0.06 | 2.74% Avg Daily Range (90 D): $0.09 | 3.70% Institutional Daily Volume Avg Daily Volume: 1.38M Avg Daily Volume (30 D): 3.82M Avg Daily Volume (90 D): 4.89M Trade Size Avg Trade Size (Sh.): 190 Avg Trade Size (Sh.) (30 D): 411 Avg Trade Size (Sh.) (90 D): 426 Institutional Trades Total Inst.Trades: 2,929 Avg Inst. Trade: $1.8M Avg Inst. Trade (30 D): $1.16M Avg Inst. Trade (90 D): $1.49M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.26M Avg Closing Trade (30 D): $1.29M Avg Closing Trade (90 D): $1.02M Avg Closing Volume: 105.55K     News Feb 18, 2025 @ 1:00 PM Esperion to Report Fourth Quarter and Full Year 20... Source: N/A Dec 18, 2024 @ 12:00 PM Esperion Strengthens Balance Sheet with Closing of... Source: N/A Dec 13, 2024 @ 11:00 AM Esperion Announces $210 Million Convertible Debt F... Source: Globe Newswire Dec 12, 2024 @ 1:00 PM Esperion Partners with Neopharm to Commercialize N... Source: N/A Nov 7, 2024 @ 11:00 AM Esperion Reports Third Quarter 2024 Financial Resu... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.66 $-.15 $-.33 Diluted EPS $-.66 $-.15 $-.33 Revenue $ 295.45M $ 51.63M $ 73.83M Gross Profit $ $ $ Net Income / Loss $ -86.77M $ -29.52M $ -61.93M Operating Income / Loss $ 16.46M $ -16.03M $ 2.58M Cost of Revenue $ $ $ Net Cash Flow $ 29.88M $ -44.59M $ -37.31M PE Ratio     Splits Jun 11, 2013:   7:1